Enhancing Dental Pulp Stem Cell Proliferation and Odontogenic Differentiation with Protein Phosphatase 1-Disrupting Peptide: An In Vitro Study.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
03 Jul 2024
Historique:
received: 25 03 2024
revised: 25 06 2024
accepted: 27 06 2024
medline: 12 7 2024
pubmed: 12 7 2024
entrez: 12 7 2024
Statut: epublish

Résumé

The reparative and regenerative capabilities of dental pulp stem cells (DPSCs) are crucial for responding to pulp injuries, with protein phosphatase 1 (PP1) playing a significant role in regulating cellular functions pertinent to tissue healing. Accordingly, this study aimed to explore the effects of a novel cell-penetrating peptide Modified Sperm Stop 1-MSS1, that disrupts PP1, on the proliferation and odontogenic differentiation of DPSCs. Employing MSS1 as a bioportide, DPSCs were cultured and characterized for metabolic activity, cell proliferation, and cell morphology alongside the odontogenic differentiation through gene expression and alkaline phosphatase (ALP) activity analysis. MSS1 exposure induced early DPSC proliferation, upregulated genes related to odontogenic differentiation, and increased ALP activity. Markers associated with early differentiation events were induced at early culture time points and those associated with matrix mineralization were upregulated at mid-culture stages. This investigation is the first to document the potential of a PP1-disrupting bioportide in modulating DPSC functionality, suggesting a promising avenue for enhancing dental tissue regeneration and repair.

Identifiants

pubmed: 38994993
pii: cells13131143
doi: 10.3390/cells13131143
pii:
doi:

Substances chimiques

Protein Phosphatase 1 EC 3.1.3.16
Peptides 0
Alkaline Phosphatase EC 3.1.3.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fundação para a Ciência e Tecnologia
ID : 2022.06464.PTDC

Auteurs

Anna Kobrock (A)

Signal Transduction Laboratory, Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal.
BoneLab-Laboratory for Bone Metabolism and Regeneration, Faculty of Dental Medicine, University of Porto, 4200-393 Porto, Portugal.
LAQV/REQUIMTE, Faculty of Dental Medicine, University of Porto, 4200-393 Porto, Portugal.

Bárbara Matos (B)

Signal Transduction Laboratory, Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal.

Daniela Patrício (D)

Signal Transduction Laboratory, Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal.

Liliana Grenho (L)

BoneLab-Laboratory for Bone Metabolism and Regeneration, Faculty of Dental Medicine, University of Porto, 4200-393 Porto, Portugal.
LAQV/REQUIMTE, Faculty of Dental Medicine, University of Porto, 4200-393 Porto, Portugal.

John Howl (J)

Research Institute in Healthcare Science, University of Wolverhampton, Wolverhampton WV1 1LY, UK.

Margarida Fardilha (M)

Signal Transduction Laboratory, Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal.

Pedro S Gomes (PS)

BoneLab-Laboratory for Bone Metabolism and Regeneration, Faculty of Dental Medicine, University of Porto, 4200-393 Porto, Portugal.
LAQV/REQUIMTE, Faculty of Dental Medicine, University of Porto, 4200-393 Porto, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH